Back
ACADIA Pharmaceuticals Vs. Regulus Therapeutics Industry Stock Comparison
Sell
28
ACAD
ACADIA Pharmaceuticals
Last Price:
14.78
Seasonality Move:
10.16%
Sell
35
RGLS
Regulus Therapeutics
Last Price:
1.99
Seasonality Move:
-26.42%
Sell
28
ACADIA Pharmaceuticals (ACAD)
is a Sell
Is ACADIA Pharmaceuticals a Buy, Sell or Hold?
- The current ACADIA Pharmaceuticals [ACAD] share price is $14.79. The Score for ACAD is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- ACAD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Regulus Therapeutics (RGLS)
is a Sell
Is Regulus Therapeutics a Buy, Sell or Hold?
- The current Regulus Therapeutics [RGLS] share price is $2.00. The Score for RGLS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- RGLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACAD Stock Price Chart
What is ACADIA Pharmaceuticals's stock price today?
-
The ACADIA Pharmaceuticals share price today is $14.79
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACAD is experiencing slight buying pressure.
RGLS Stock Price Chart
What is Regulus Therapeutics's stock price today?
-
The Regulus Therapeutics share price today is $2.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGLS is experiencing slight selling pressure.
ACAD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.85 | Sell |
| Relative Strength Index (14 RSI): | 27.33 | Sell |
| Chaikin Money Flow: | 151188 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.52 - 17.28) | Sell |
| Bollinger Bands (100): | (17.12 - 27.4) | Sell |
RGLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 37.73 | Sell |
| Chaikin Money Flow: | -87775 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.09 - 2.51) | Sell |
| Bollinger Bands (100): | (1.31 - 2.47) | Buy |
ACAD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.3 | Sell |
| 20-day SMA: | 16.25 | Sell |
| 50-day SMA: | 17.56 | Sell |
| 200-day SMA: | 23.46 | Sell |
| 8-day EMA: | 15.32 | Sell |
| 20-day EMA: | 16.12 | Sell |
| 50-day EMA: | 17.99 | Sell |
| 200-day EMA: | 21.82 | Sell |
RGLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.11 | Sell |
| 20-day SMA: | 2.28 | Sell |
| 50-day SMA: | 2.41 | Sell |
| 200-day SMA: | 1.64 | Buy |
| 8-day EMA: | 2.11 | Sell |
| 20-day EMA: | 2.25 | Sell |
| 50-day EMA: | 2.23 | Sell |
| 200-day EMA: | 1.81 | Buy |
ACADIA Pharmaceuticals Earnings Growth & ACAD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.59 per share, an increase next quarter of $0.02 per share, an increase this year of $0.88 per share, and an increase next year of $0.53 per share.
Regulus Therapeutics Earnings Growth & RGLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.95 per share, and a decrease next year of $0.12 per share.
ACADIA Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regulus Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||